 | • レポートコード：MRC2-11QY03231 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生物学的薬剤のグローバル市場について調査・分析したレポートです。種類別（フミラ、レミケード、リツキサン、エンブレル、ランタス、アバスチン、ハーセプチン、その他）市場規模、用途別（糖尿病、炎症、自己免疫疾患、血液疾患、循環器疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生物学的薬剤の競争状況、市場シェア ・世界の生物学的薬剤市場：種類別市場規模 2015年-2020年（フミラ、レミケード、リツキサン、エンブレル、ランタス、アバスチン、ハーセプチン、その他） ・世界の生物学的薬剤市場：種類別市場規模予測 2021年-2026年（フミラ、レミケード、リツキサン、エンブレル、ランタス、アバスチン、ハーセプチン、その他） ・世界の生物学的薬剤市場：用途別市場規模 2015年-2020年（糖尿病、炎症、自己免疫疾患、血液疾患、循環器疾患、その他） ・世界の生物学的薬剤市場：用途別市場規模予測 2021年-2026年（糖尿病、炎症、自己免疫疾患、血液疾患、循環器疾患、その他） ・北米の生物学的薬剤市場分析：米国、カナダ ・ヨーロッパの生物学的薬剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生物学的薬剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生物学的薬剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生物学的薬剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Abbott Laboratories、Johnson & Johnson、Merck & Co.、Pfizer、Amgen、Sanofi、Novartis、Eli Lilly、Amgen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Biologic Drugs Market
The global Biologic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biologic Drugs Scope and Market Size
Biologic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biologic Drugs market is segmented into
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Segment by Application, the Biologic Drugs market is segmented into
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
Regional and Country-level Analysis
The Biologic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biologic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biologic Drugs Market Share Analysis
Biologic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biologic Drugs business, the date to enter into the Biologic Drugs market, Biologic Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
1 Study Coverage
1.1 Biologic Drugs Product Introduction
1.2 Market Segments
1.3 Key Biologic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biologic Drugs Market Size Growth Rate by Type
1.4.2 Humira
1.4.3 Remicade
1.4.4 Rituxan
1.4.5 Enbrel
1.4.6 Lantus
1.4.7 Avastin
1.4.8 Herceptin
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biologic Drugs Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Inflammation
1.5.4 Auto-Immune Diseases
1.5.5 Blood Diseases
1.5.6 Cardiovascular Diseases
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biologic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Biologic Drugs Revenue 2015-2026
2.1.2 Global Biologic Drugs Sales 2015-2026
2.2 Global Biologic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biologic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biologic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biologic Drugs Competitor Landscape by Players
3.1 Biologic Drugs Sales by Manufacturers
3.1.1 Biologic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Biologic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Biologic Drugs Revenue by Manufacturers
3.2.1 Biologic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Biologic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biologic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biologic Drugs Revenue in 2019
3.2.5 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biologic Drugs Price by Manufacturers
3.4 Biologic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biologic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biologic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biologic Drugs Market Size by Type (2015-2020)
4.1.1 Global Biologic Drugs Sales by Type (2015-2020)
4.1.2 Global Biologic Drugs Revenue by Type (2015-2020)
4.1.3 Biologic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biologic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Biologic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Biologic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Biologic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biologic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biologic Drugs Market Size by Application (2015-2020)
5.1.1 Global Biologic Drugs Sales by Application (2015-2020)
5.1.2 Global Biologic Drugs Revenue by Application (2015-2020)
5.1.3 Biologic Drugs Price by Application (2015-2020)
5.2 Biologic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Biologic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Biologic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Biologic Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biologic Drugs by Country
6.1.1 North America Biologic Drugs Sales by Country
6.1.2 North America Biologic Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biologic Drugs Market Facts & Figures by Type
6.3 North America Biologic Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Biologic Drugs by Country
7.1.1 Europe Biologic Drugs Sales by Country
7.1.2 Europe Biologic Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologic Drugs Market Facts & Figures by Type
7.3 Europe Biologic Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biologic Drugs by Region
8.1.1 Asia Pacific Biologic Drugs Sales by Region
8.1.2 Asia Pacific Biologic Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biologic Drugs Market Facts & Figures by Type
8.3 Asia Pacific Biologic Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biologic Drugs by Country
9.1.1 Latin America Biologic Drugs Sales by Country
9.1.2 Latin America Biologic Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biologic Drugs Market Facts & Figures by Type
9.3 Central & South America Biologic Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biologic Drugs by Country
10.1.1 Middle East and Africa Biologic Drugs Sales by Country
10.1.2 Middle East and Africa Biologic Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biologic Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Biologic Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Biologic Drugs Products Offered
11.1.5 Roche Related Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Description and Business Overview
11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Laboratories Biologic Drugs Products Offered
11.2.5 Abbott Laboratories Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Biologic Drugs Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Description and Business Overview
11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co. Biologic Drugs Products Offered
11.4.5 Merck & Co. Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Biologic Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Description and Business Overview
11.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Amgen Biologic Drugs Products Offered
11.6.5 Amgen Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Biologic Drugs Products Offered
11.7.5 Sanofi Related Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description and Business Overview
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Biologic Drugs Products Offered
11.8.5 Novartis Related Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Description and Business Overview
11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly Biologic Drugs Products Offered
11.9.5 Eli Lilly Related Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Description and Business Overview
11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Amgen Biologic Drugs Products Offered
11.10.5 Amgen Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Biologic Drugs Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biologic Drugs Market Estimates and Projections by Region
12.1.1 Global Biologic Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Biologic Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Biologic Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Biologic Drugs Sales Forecast (2021-2026)
12.2.2 North America: Biologic Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Biologic Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Biologic Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Biologic Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Biologic Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Biologic Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biologic Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biologic Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biologic Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biologic Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Biologic Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Biologic Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Biologic Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Biologic Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biologic Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biologic Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biologic Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biologic Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biologic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Biologic Drugs Market Segments
Table 2. Ranking of Global Top Biologic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biologic Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Humira
Table 5. Major Manufacturers of Remicade
Table 6. Major Manufacturers of Rituxan
Table 7. Major Manufacturers of Enbrel
Table 8. Major Manufacturers of Lantus
Table 9. Major Manufacturers of Avastin
Table 10. Major Manufacturers of Herceptin
Table 11. Major Manufacturers of Others
Table 12. Global Biologic Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Biologic Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Biologic Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Biologic Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Biologic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Biologic Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Biologic Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Biologic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Drugs as of 2019)
Table 21. Biologic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Biologic Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Biologic Drugs Price (2015-2020) (USD/Unit)
Table 24. Biologic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Biologic Drugs Product Type
Table 26. Date of International Manufacturers Enter into Biologic Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 29. Global Biologic Drugs Sales Share by Type (2015-2020)
Table 30. Global Biologic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Biologic Drugs Revenue Share by Type (2015-2020)
Table 32. Biologic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 34. Global Biologic Drugs Sales Share by Application (2015-2020)
Table 35. North America Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 36. North America Biologic Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 40. North America Biologic Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 42. North America Biologic Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 44. Europe Biologic Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 48. Europe Biologic Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 50. Europe Biologic Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Biologic Drugs Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Biologic Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Biologic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Biologic Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Biologic Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Biologic Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 60. Latin America Biologic Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 64. Latin America Biologic Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 66. Latin America Biologic Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Biologic Drugs Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Biologic Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Biologic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Biologic Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Biologic Drugs Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Biologic Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Biologic Drugs Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Biologic Drugs Sales Market Share by Application (2015-2020)
Table 75. Roche Corporation Information
Table 76. Roche Description and Major Businesses
Table 77. Roche Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Roche Product
Table 79. Roche Recent Development
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Major Businesses
Table 82. Abbott Laboratories Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Major Businesses
Table 87. Johnson & Johnson Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Recent Development
Table 90. Merck & Co. Corporation Information
Table 91. Merck & Co. Description and Major Businesses
Table 92. Merck & Co. Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck & Co. Product
Table 94. Merck & Co. Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Major Businesses
Table 97. Pfizer Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Amgen Corporation Information
Table 101. Amgen Description and Major Businesses
Table 102. Amgen Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Amgen Product
Table 104. Amgen Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sanofi Product
Table 109. Sanofi Recent Development
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Major Businesses
Table 112. Novartis Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Novartis Product
Table 114. Novartis Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Major Businesses
Table 117. Eli Lilly Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Eli Lilly Product
Table 119. Eli Lilly Recent Development
Table 120. Amgen Corporation Information
Table 121. Amgen Description and Major Businesses
Table 122. Amgen Biologic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Amgen Product
Table 124. Amgen Recent Development
Table 125. Global Biologic Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Biologic Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Biologic Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Biologic Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Biologic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Biologic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Biologic Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Biologic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Biologic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Biologic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Biologic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Biologic Drugs Players
Table 143. Biologic Drugs Customers List
Table 144. Biologic Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Drugs Product Picture
Figure 2. Global Biologic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Humira Product Picture
Figure 4. Remicade Product Picture
Figure 5. Rituxan Product Picture
Figure 6. Enbrel Product Picture
Figure 7. Lantus Product Picture
Figure 8. Avastin Product Picture
Figure 9. Herceptin Product Picture
Figure 10. Others Product Picture
Figure 11. Global Biologic Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Diabetes
Figure 13. Inflammation
Figure 14. Auto-Immune Diseases
Figure 15. Blood Diseases
Figure 16. Cardiovascular Diseases
Figure 17. Others
Figure 18. Biologic Drugs Report Years Considered
Figure 19. Global Biologic Drugs Market Size 2015-2026 (US$ Million)
Figure 20. Global Biologic Drugs Sales 2015-2026 (K Units)
Figure 21. Global Biologic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 22. Global Biologic Drugs Sales Market Share by Region (2015-2020)
Figure 23. Global Biologic Drugs Sales Market Share by Region in 2019
Figure 24. Global Biologic Drugs Revenue Market Share by Region (2015-2020)
Figure 25. Global Biologic Drugs Revenue Market Share by Region in 2019
Figure 26. Global Biologic Drugs Sales Share by Manufacturer in 2019
Figure 27. The Top 10 and 5 Players Market Share by Biologic Drugs Revenue in 2019
Figure 28. Biologic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Biologic Drugs Sales Market Share by Type (2015-2020)
Figure 30. Global Biologic Drugs Sales Market Share by Type in 2019
Figure 31. Global Biologic Drugs Revenue Market Share by Type (2015-2020)
Figure 32. Global Biologic Drugs Revenue Market Share by Type in 2019
Figure 33. Global Biologic Drugs Market Share by Price Range (2015-2020)
Figure 34. Global Biologic Drugs Sales Market Share by Application (2015-2020)
Figure 35. Global Biologic Drugs Sales Market Share by Application in 2019
Figure 36. Global Biologic Drugs Revenue Market Share by Application (2015-2020)
Figure 37. Global Biologic Drugs Revenue Market Share by Application in 2019
Figure 38. North America Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 39. North America Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Biologic Drugs Sales Market Share by Country in 2019
Figure 41. North America Biologic Drugs Revenue Market Share by Country in 2019
Figure 42. U.S. Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. U.S. Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Canada Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. North America Biologic Drugs Market Share by Type in 2019
Figure 47. North America Biologic Drugs Market Share by Application in 2019
Figure 48. Europe Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 49. Europe Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Biologic Drugs Sales Market Share by Country in 2019
Figure 51. Europe Biologic Drugs Revenue Market Share by Country in 2019
Figure 52. Germany Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Germany Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. France Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. U.K. Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Italy Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Russia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Europe Biologic Drugs Market Share by Type in 2019
Figure 63. Europe Biologic Drugs Market Share by Application in 2019
Figure 64. Asia Pacific Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 65. Asia Pacific Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Biologic Drugs Sales Market Share by Region in 2019
Figure 67. Asia Pacific Biologic Drugs Revenue Market Share by Region in 2019
Figure 68. China Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. China Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Japan Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. South Korea Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. India Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Australia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Taiwan Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Indonesia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Thailand Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Malaysia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Philippines Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Vietnam Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Asia Pacific Biologic Drugs Market Share by Type in 2019
Figure 91. Asia Pacific Biologic Drugs Market Share by Application in 2019
Figure 92. Latin America Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 93. Latin America Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 94. Latin America Biologic Drugs Sales Market Share by Country in 2019
Figure 95. Latin America Biologic Drugs Revenue Market Share by Country in 2019
Figure 96. Mexico Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 97. Mexico Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Brazil Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Brazil Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Argentina Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Argentina Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Latin America Biologic Drugs Market Share by Type in 2019
Figure 103. Latin America Biologic Drugs Market Share by Application in 2019
Figure 104. Middle East and Africa Biologic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 105. Middle East and Africa Biologic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 106. Middle East and Africa Biologic Drugs Sales Market Share by Country in 2019
Figure 107. Middle East and Africa Biologic Drugs Revenue Market Share by Country in 2019
Figure 108. Turkey Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. Turkey Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Saudi Arabia Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 111. Saudi Arabia Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. U.A.E Biologic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 113. U.A.E Biologic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 114. Middle East and Africa Biologic Drugs Market Share by Type in 2019
Figure 115. Middle East and Africa Biologic Drugs Market Share by Application in 2019
Figure 116. North America Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. North America Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Europe Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Asia Pacific Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Latin America Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Biologic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Middle East and Africa Biologic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
コレステロール低下生物学的薬剤の世界市場（～2026年） The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad chol…- 生物学的治療薬の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…
- 生物学的治療の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…
- 生物学用シングルユース技術の世界市場（～2026年） Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies. Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market. Market Analysis and Insights: Global Single-Use …
- 生物学的反応修飾因子の世界市場（～2026年） Biologic response modifiers modulate the immune system to combat infections and diseases. These novel class of drugs are used for immunotherapy, and are thus manufactured in pharmaceutical industries in large volume to enhance or suppress the activity of immune system. Market Analysis and Insights: …